| Title | Blood advances |
| Abbreviation | Blood adv. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Hematology (Q1) |
| h-index | 69 |
| Overall Rank/Ranking | 589 |
| SCImago Journal Rank (SJR) | 3.070 |
| Impact Score | 6.69 |
| Publisher | Elsevier BV |
| Country | United States |
| ISSN | 24739529, 24739537 |
| Best Quartile | Q1 |
| Coverage History | 2017-2022 |
Blood advances is a journal covering the technologies/fields/categories related to Hematology (Q1). It is published by Elsevier BV. The overall rank of Blood advances is 589. According to SCImago Journal Rank (SJR), this journal is ranked 3.070. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 69. The best quartile for this journal is Q1.
The ISSN of Blood advances journal is 24739529, 24739537. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Blood advances is cited by a total of 10735 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Blood advances is 6.69, which is computed in 2023 as per its definition. Blood advances IF is increased by a factor of 0.23 and approximate percentage change is 3.56% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Blood advances is 6.69. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6.69 |
| 2021 | 6.46 |
| 2020 | 5.50 |
| 2019 | 4.40 |
| 2018 | 2.77 |
| 2017 | 0.00 |
Blood advances has an h-index of 69. It means 69 articles of this journal have more than 69 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Blood advances is 24739529, 24739537. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Blood advances is 589. According to SCImago Journal Rank (SJR), this journal is ranked 3.070. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 3.070 |
| 2021 | 2.795 |
| 2020 | 2.685 |
| 2019 | 2.226 |
| 2018 | |
| 2017 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 589 |
| 2021 | 673 |
| 2020 | 786 |
| 2019 | 1089 |
| 2018 | 31854 |
| 2017 | 32595 |
Blood advances is published by Elsevier BV. It's publishing house is located in United States. Coverage history of this journal is as following: 2017-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Blood advances is Blood adv.. This abbreviation ('Blood adv.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Hematology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Blood advances latest impact IF is 6.69. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 6.69 (2022) and 0.00 (2017), respectively, in the last 6 years. Moreover, its average IS is 4.3 in the previous 6 years.
The Blood advances has an SJR (SCImago Journal Rank) of 3.070, according to the latest data. It is computed in the year 2023. In the past 6 years, this journal has recorded a range of SJR, with the highest being 3.070 in 2022 and the lowest being in 2018. Furthermore, the average SJR of the Blood advances over the previous 6-year period stands at 4.3.
The latest h-index of the Blood advances is 69.
The Blood advances is published by the Elsevier BV, with its country of publication being the United States.
The Blood advances is currently ranked 589 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 6 years, this journal has experienced varying rankings, reaching its highest position of 589 in 2022 and its lowest position of 32595 in 2017.
The standard ISO4 abbreviation for the Blood advances is Blood adv..
Blood advances is classified as a journal that the Elsevier BV publishes.
The Blood advances encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Blood advances is assigned the following International Standard Serial Numbers (ISSN): 24739529, 24739537.
The best quartile for the Blood advances is Q1 (2022).
The Blood advances coverage history can be summarized as follows: 2017-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the ASME Turbo Expo | conference and proceedings | 17577 | 54 | 0.00 | |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Discourse | journal | 6621 | Routledge | 59 | 2.11 |
| Socialism and Democracy | journal | 26162 | Taylor and Francis Ltd. | 17 | 0.09 |
| Transnational Corporations | journal | 6120 | UNCTAD United Nations Conference on Trade and Development | 27 | 1.92 |
| Libyan Studies | journal | 16122 | Cambridge University Press | 8 | 0.45 |
| Sapporo Medical Journal | journal | 20468 | Cancer Research Institute, Sapporo Medical University | 3 | 0.00 |
| Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 6.69 |
| 2021 | 6.46 |
| 2020 | 5.50 |
| 2019 | 4.40 |
| 2018 | 2.77 |
| 2017 | 0.00 |
